Capricor Therapeutics, Inc. Company Profile, Contacts & Intelligence
Capricor Therapeutics, Inc. Overview
Capricor Therapeutics is a publicly traded (NASDAQ: CAPR) biotechnology company with a mission to develop groundbreaking therapies that make a meaningful impact on patients’ lives. Capricor is focused on the development of biologics, primarily cell and exosome-based technologies to treat or prevent a broad range of diseases. Our lead product is a cell therapy designed to treat Duchenne muscular dystrophy (DMD), the most severe form of muscular dystrophy, which results in muscle degeneration and premature death. Capricor’s innovative exosome technology is focusing on engineering exosomes to treat or prevent diseases with high unmet medical needs. Our translational approach to product development is based on the strong research foundation provided by our academic partnerships with leading scientists at top-tier research institutions.
- Headquarters
- 10865 Road to the Cure
- Website
- capricor.com
- Industry
- Biotechnology Research
- Founded
- 2005
- Stock Symbol
- CAPR
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology)
- Phone Number
- Available in AeroLeads
- Company Email
- Available in AeroLeads
Capricor Therapeutics, Inc. Contact Intelligence
See which contact channels and departments are represented in the visible AeroLeads data.
Capricor Therapeutics, Inc. People & Org Chart Preview
Sample people records show job titles and whether email or phone data is available without exposing raw contact details.
Capricor Therapeutics, Inc. Workforce Composition
Seniority breakdown across 23 visible profiles.
Capricor Therapeutics, Inc. Technology & Talent
Technology-related job titles represented in the visible people data.
Compare Similar Companies to Capricor Therapeutics, Inc.
Explore companies in related markets and compare their industry and employee estimates.
| Company | Industry / match | Employee estimate | Page |
|---|---|---|---|
| Exelixis | Biotechnology Research | 1.50K | View company |
| Ionis Pharmaceuticals, Inc. | Biotechnology Research | 1.27K | View company |
| PTC Therapeutics, Inc. | Biotechnology Research | 1.18K | View company |
| Arrowhead Pharmaceuticals | Biotechnology Research | 625 | View company |
| Avidity Biosciences, Inc. | Biotechnology | 491 | View company |
| Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) | Biotechnology Research | 378 | View company |
| Poseida Therapeutics, Inc. | Biotechnology Research | 218 | View company |
| Abeona Therapeutics | Biotechnology Research | 192 | View company |
| ARS Pharmaceuticals, Inc. | Pharmaceutical Manufacturing | 163 | View company |
| Verastem Oncology | Biotechnology Research | 128 | View company |